A 5020·NJ·house
Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.
In CommitteeFiled May 7, 2026
Sponsor: Peterpaul, Luanne M.
Latest Action
Introduced First Reading Assembly Referred to AFI
May 7, 2026
Summary
The bill stops pharmacy benefit managers (PBMs) from using spread pricing and requires them to pass all rebates and fees back to health plans. It also obligates PBMs to file detailed quarterly and annual financial reports and lets the state publish a public summary. The goal is to lower drug costs for consumers and make PBM practices visible.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when A 5020 changes status, plus AI-powered summaries and stage predictions.
Sign up free